Cargando…

“On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults

The authorization of several high-efficacy vaccines for use against the novel SARS-CoV2 virus signals a transition in the global COVID-19 response. Vaccine acceptance is critical for pandemic control and has a variety of context- specific drivers that operate at the individual, group, and sociopolit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibbels, Natalie J., Dosso, Abdul, Fordham, Corinne, Benie, William, Brou, Jeanne Aka, Kamara, Diarra, Hendrickson, Zoé M., Naugle, Danielle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831134/
https://www.ncbi.nlm.nih.gov/pubmed/35181151
http://dx.doi.org/10.1016/j.vaccine.2022.02.032
_version_ 1784648435251544064
author Tibbels, Natalie J.
Dosso, Abdul
Fordham, Corinne
Benie, William
Brou, Jeanne Aka
Kamara, Diarra
Hendrickson, Zoé M.
Naugle, Danielle A.
author_facet Tibbels, Natalie J.
Dosso, Abdul
Fordham, Corinne
Benie, William
Brou, Jeanne Aka
Kamara, Diarra
Hendrickson, Zoé M.
Naugle, Danielle A.
author_sort Tibbels, Natalie J.
collection PubMed
description The authorization of several high-efficacy vaccines for use against the novel SARS-CoV2 virus signals a transition in the global COVID-19 response. Vaccine acceptance is critical for pandemic control and has a variety of context- specific drivers that operate at the individual, group, and sociopolitical levels. Social and behavior change interventions can influence individual knowledge, attitudes, and intentions as well as community norms to facilitate widespread vaccine uptake. While considerable research has been done to explore vaccine confidence in high-income populations as well as with respect to childhood vaccinations, much work remains to be done in understanding attitudes and intentions in low and middle income countries for adult or novel vaccines. We conducted in-depth interviews with individuals who had recovered from COVID-19 (n = 8), people who had lost a family member to COVID-19 (n = 4), and health providers (n = 17). We also conducted focus group discussions with members of the general population (n = 24 groups) to explore social norms and community perceptions related to COVID-19, including prevention behaviors, stigma, and vaccines. Researchers collected data in Abidjan, Côte d’Ivoire, in November 2020. In considering whether to accept a future COVID-19 vaccine or not, individuals in the study weighed perceived risk of the vaccine against the severity of the disease. Perceived severity of rumored side effects or safety issues of vaccines were also a factor. Convenience was a secondary, albeit also important, consideration. While concerns about vaccine safety tended to produce an expressed intention to delay vaccination, conspiracy theories about those developing and promoting vaccines and their motives led people to say they would opt out entirely. Behavior change interventions must raise awareness and address misunderstandings about the purpose of vaccines, transparently communicate about vaccine safety and development processes, and engage trusted influencers to build an enabling environment for COVID-19 vaccine roll out.
format Online
Article
Text
id pubmed-8831134
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88311342022-02-11 “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults Tibbels, Natalie J. Dosso, Abdul Fordham, Corinne Benie, William Brou, Jeanne Aka Kamara, Diarra Hendrickson, Zoé M. Naugle, Danielle A. Vaccine Article The authorization of several high-efficacy vaccines for use against the novel SARS-CoV2 virus signals a transition in the global COVID-19 response. Vaccine acceptance is critical for pandemic control and has a variety of context- specific drivers that operate at the individual, group, and sociopolitical levels. Social and behavior change interventions can influence individual knowledge, attitudes, and intentions as well as community norms to facilitate widespread vaccine uptake. While considerable research has been done to explore vaccine confidence in high-income populations as well as with respect to childhood vaccinations, much work remains to be done in understanding attitudes and intentions in low and middle income countries for adult or novel vaccines. We conducted in-depth interviews with individuals who had recovered from COVID-19 (n = 8), people who had lost a family member to COVID-19 (n = 4), and health providers (n = 17). We also conducted focus group discussions with members of the general population (n = 24 groups) to explore social norms and community perceptions related to COVID-19, including prevention behaviors, stigma, and vaccines. Researchers collected data in Abidjan, Côte d’Ivoire, in November 2020. In considering whether to accept a future COVID-19 vaccine or not, individuals in the study weighed perceived risk of the vaccine against the severity of the disease. Perceived severity of rumored side effects or safety issues of vaccines were also a factor. Convenience was a secondary, albeit also important, consideration. While concerns about vaccine safety tended to produce an expressed intention to delay vaccination, conspiracy theories about those developing and promoting vaccines and their motives led people to say they would opt out entirely. Behavior change interventions must raise awareness and address misunderstandings about the purpose of vaccines, transparently communicate about vaccine safety and development processes, and engage trusted influencers to build an enabling environment for COVID-19 vaccine roll out. The Authors. Published by Elsevier Ltd. 2022-03-18 2022-02-11 /pmc/articles/PMC8831134/ /pubmed/35181151 http://dx.doi.org/10.1016/j.vaccine.2022.02.032 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tibbels, Natalie J.
Dosso, Abdul
Fordham, Corinne
Benie, William
Brou, Jeanne Aka
Kamara, Diarra
Hendrickson, Zoé M.
Naugle, Danielle A.
“On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
title “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
title_full “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
title_fullStr “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
title_full_unstemmed “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
title_short “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
title_sort “on the last day of the last month, i will go”: a qualitative exploration of covid-19 vaccine confidence among ivoirian adults
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831134/
https://www.ncbi.nlm.nih.gov/pubmed/35181151
http://dx.doi.org/10.1016/j.vaccine.2022.02.032
work_keys_str_mv AT tibbelsnataliej onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT dossoabdul onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT fordhamcorinne onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT beniewilliam onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT broujeanneaka onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT kamaradiarra onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT hendricksonzoem onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults
AT naugledaniellea onthelastdayofthelastmonthiwillgoaqualitativeexplorationofcovid19vaccineconfidenceamongivoirianadults